← FDA DRUG APPROVALS
FDA NDA · NDA050566
ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER
Sponsor: BAXTER HLTHCARE
APPLICATION
NDA050566
TYPE
NDA
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER · ReferenceDiscontinued
CEFAZOLIN SODIUM EQ 20MG BASE/ML · INJECTABLE · INJECTION
ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER · ReferenceDiscontinued
CEFAZOLIN SODIUM EQ 20MG BASE/ML · INJECTABLE · INJECTION
ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER · ReferenceDiscontinued
CEFAZOLIN SODIUM EQ 10MG BASE/ML · INJECTABLE · INJECTION
ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER · ReferenceDiscontinued
CEFAZOLIN SODIUM EQ 10MG BASE/ML · INJECTABLE · INJECTION
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.